GlassScriptPhysician profile
Michael S Kluska
NPI 1184621757
$58,026.27
in general payments reported to CMS, 2019-2025
11 companies · $695 in 2025
The $695 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $34K · 2021: $376 · 2022: $808 · 2023: $978 · 2024: $510 · 2025: $695.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,315 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $868.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,314.51 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $867.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Apyx Medical Corporation | $53,847.70 | 2019-2020 | |
| Allergan, INC. | $1,662.90 | 2019-2023 | |
| Abbvie INC. | $1,519.32 | 2023-2025 | |
| Merz North America, INC. | $539.98 | 2019-2020 | |
| Clozex Medical INC | $242.69 | 2023-2024 | Clozex Skin Closure Device |
| Solta Medical, A Division of Bausch Health US, LLC | $101.06 | 2023 | |
| Mentor Worldwide LLC | $50.35 | 2019-2020 | |
| Eagle Pharmaceuticals, INC. | $21.16 | 2019 | |
| Motiva USA, LLC | $17.24 | 2025 | |
| Smith+Nephew, INC. | $13.15 | 2022 | |
| Heron Therapeutics, INC. | $10.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Kluska listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.